https://pittplusme.org/study/809
Study to Evaluate PF-04965842 In Subjects With Moderate To Severe Atopic Dermatitis
We're sorry. This study is closed and no longer recruiting participants.
STUDY BASICS
Are you between 18-75 years of age and have you been diagnosed with atopic dermatitis (also known eczema)? If so, you may be eligible to participate in a study to help evaluate the safety and efficacy of an investigational medication to help treat atopic dermatitis. Compensation provided.
IRB: 20160010
- A Phase 2B Randomized, Double-Blind, Placebo-Controlled, Parallel, Multicenter, Dose-Ranging, Study to Evaluate the Efficacy and Safety Profile of PF-04965842 in Subjects with Moderate to Severe Atopic Dermatitis
AGE:
18 - 75
COMPENSATION:
$760.00
Participants may be reimbursed for reasonable travel expenses (to include mileage, parking fees, etc.) necessary to their participation in the study.
SHARE STUDY
MEET THE RESEARCHER
Laura Ferris
Laura Korb Ferris, MD, PhD, is Professor of Dermatology at the University of Pittsburgh School of Medicine, and is also the Director of Clinical Trials for the Department of Dermatology. Dr. Ferris earned her doctorate in immunology from Johns Hopkins University and her medical degree from the University of Maryland.